The Motivator: Summer/Fall 2011
By Diana M. Schneider, PhD
Jack Burks, MD
This annual Research Update provides a comprehensive overview of the eight FDA-approved disease-modifying therapies used to slow MS activity as well as initial findings on many of the experimental treatments.
By Douglas G. Franklin
MSAA's president and CEO talks about MSAA's newest programs, plus our collaboration with other organizations to better understand and address the needs of the MS community.
By Jack Burks, MD
MSAA's chief medical officer answers questions sent in by readers.
By Susan Wells Courtney
An update on CCSVI is given, plus Botox receives a new approval.
By Peter Damiri
MSAA's free mobile app, My MS Manager™, is featured.
By Neal Zoren
This column explains the ease and affordability of sustainer gifts.
By Alba S. Morton
Alba writes about her brother David, who uses computer software to create award-winning works of art.
Three informative books from MSAA's Lending Library are featured.